You have 9 free searches left this month | for more free features.

Condition

Solid Tumors (2)

Breast Cancer (1)

Colorectal Cancer (1)

Early-Stage Breast Carcinoma (1)

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast (1)

Overall Status

Completed (2)

Not yet recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 1 (2)

early phase 1 (1)

phase 1/phase 2 (1)

Sponsor

MEI Pharma, Inc. (3)

Centro Nacional de Investigaciones Oncologicas CARLOS III (1)

Collaborator

SCRI Development Innovations, LLC (2)

Fundacion CRIS de Investigacion para Vencer el Cancer (1)

Intervention

me-344 (4)

bevacizumab (2)

normal saline (1)

topotecan (1)

Study Documents

Intervention Type

drug (4)

other (1)

Funder Type

Industry (3)

Other (1)

Study Type

Interventional (4)

me-344

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Colorectal Cancer Trial (ME-344, Bevacizumab)

Not yet recruiting

Colorectal Cancer

ME-344
Bevacizumab

(no location specified)

Apr 20, 2023

Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Early-Stage Breast Carcinoma Trial in Fuenlabrada,

Completed

Breast Cancer
+2 more

ME-344
+2 more

Fuenlabrada, Madrid, Spain
+4 more

Jul 22, 2019

Solid Tumors Trial in United Kingdom, United States (ME-344, Topotecan)

Terminated

Has Results

Solid Tumors

ME-344
Topotecan

Scottsdale, Arizona
+9 more

Sep 28, 2017

Solid Tumors Trial in Sarasota, Oklahoma City, Nashville (ME-344)

Completed

Solid Tumors

ME-344

Sarasota, Florida
+2 more

Jun 17, 2015